Bioengineered soluble ACE2 for brain protection against SARS-CoV-2 infection
In a recent study published on bioRxiv* preprint server, researchers compared the efficacy of bioengineered soluble angiotensin-converting enzyme-2 (ACE-2) in protecting the brain during coronavirus disease 2019 (COVID-19). Study: Superiority of intranasal over systemic administration of bioengineered soluble ACE2 for survival and brain protection against SARS-CoV-2 infection. Image credit: Kateryna Kon/Shutterstock Background Studies have noted …
Bioengineered soluble ACE2 for brain protection against SARS-CoV-2 infection Read More »